SCHEMBL4201599

SCHEMBL4201599

COC(=O)c1nn2c(c1O)c(=O)[nH]c1ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 7/20 0.46
ERCC1 P07992 1/20 0.44
FEN1 P39748 1/20 0.44
ERCC4 Q92889 1/20 0.44
KDM4E B2RXH2 3/20 0.44
STAT3 P40763 1/20 0.44
HIF1A Q16665 1/20 0.44
RNASEH1 O60930 1/20 0.42
PDE2A O00408 1/20 0.41
PDE6D O43924 1/20 0.41
PDE8A O60658 1/20 0.41
PDE5A O76074 1/20 0.41
PDE9A O76083 1/20 0.41
PDE8B O95263 1/20 0.41
PDE6A P16499 1/20 0.41
PDE6G P18545 1/20 0.41
PDE4A P27815 1/20 0.41
PDE6B P35913 1/20 0.41
PDE6C P51160 1/20 0.41
PDE1A P54750 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13947737 0.80 ADORA3 (0.51) ADORA3KDM4ESTAT3HIF1ARNASEH1
SCHEMBL30273106 0.73 PDE2A (0.51) ADORA3KDM4EPDE2APDE6DPDE8A
SCHEMBL823324 0.70 MEN1 (0.49) ADORA3ERCC1FEN1ERCC4KDM4E
SCHEMBL12808368 0.69 ADORA3 (0.52) ADORA3KDM4EPDE9AALDH1A1HSD17B10
SCHEMBL30273093 0.68 PARP1 (0.54) ADORA3KDM4EPDE2APDE6DPDE8A
SCHEMBL30577456 0.68 PDE2A (0.49) ADORA3KDM4EPDE2APDE6DPDE8A
SCHEMBL30273116 0.68 PDE2A (0.49) ADORA3KDM4EPDE2APDE6DPDE8A
SCHEMBL5322245 0.67 HPGD (0.61) ERCC1FEN1ERCC4KDM4ESTAT3
SCHEMBL4195433 0.66 ADORA3 (0.44) ADORA3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL1622313 0.64 KDM4E (0.71) KDM4EALDH1A1MEN1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476666-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2009-01-13 US disclosed
US-20080015187-A1 Hiv Integrase Inhibitors MERCK SHARP & DOHME CORP. 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015187-A1 Hiv Integrase Inhibitors REV1, ZC3HAV1, PNP ADORA3 657/4885ERCC1 1105/4885FEN1 131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.